October 31, 2017 BY Valentina Kirilova
Theranexus takes its first steps on Euronext Growth
Theranexus, a French biotech company that develops drugs for the treatment of central nervous system disorders, announced its listing on Euronext Growth (ticker code: ALTHX). Theranexus was part of the first TechShare class of 2015, and is the third company in the programme to go public, joining a community of over 330 tech companies listed…
Read more